C1R, CCL2, and TNFRSF1A Genes in Coronavirus Disease-COVID-19 Pathway Serve as Novel Molecular Biomarkers of GBM Prognosis and Immune Infiltration

<div>The correlation between the expression levels of three key DEGs and the survival rate of GBM patients: (a) C1R, (b) CCL2, and (c) TNFRSF1A.</div>

Disease Markers

fig5

Figure 5

Figure 5: C1R, CCL2, and TNFRSF1A Genes in Coronavirus Disease-COVID-19 Pathway Serve as Novel Molecular Biomarkers of GBM Prognosis and Immune Infiltration 

Figure 5 | C1R, CCL2, and TNFRSF1A Genes in Coronavirus Disease-COVID-19 Pathway Serve as Novel Molecular Biomarkers of GBM Prognosis and Immune Infiltration 